Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 50 for Polycystic Kidney Disease

Edit search filters
  1. Safety, Tolerability And Pharmacokinetics Of AZD1613 In Adults With Autosomal Dominant Polycystic Kidney Disease

    Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate Bardoxolone Methyl In Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Rochester, MN

  3. A Study To Evaluate The Long Term Safety Of Titrated Immediate-Release Tolvaptan In Subjects With Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  4. A Safety, Pharmacokinetic And Dose-Escalation Study Of KD019 In Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Rochester, MN

  5. A Study Of RGLS8429 In Patients With Autosomal Dominant Polycystic Kidney Disease

    Jacksonville, FL, Rochester, MN

  6. Caloric Restriction in Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  7. Open-Label Tolvaptan Study in Subjects With ADPKD

    Rochester, MN

  8. PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

    Jacksonville, FL

  9. A Study of Quality of Life and Pain Control Before and After Endovascular Renal Denervation in Individuals with Refractory Kidney Pain

    Rochester, MN

  10. The ELiSA Study - Evaluation Of Lixivaptan In Subjects With Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

.

Mayo Clinic Footer